ClinicalTrials.govpublic full text
A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer
stage iv pancreatic cancer, newly diagnosed stage iv pancreatic cancer, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 849039
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.